-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on Disc Medicine, Raises Price Target to $170

Benzinga·10/19/2026 14:36:04
Cantor Fitzgerald analyst Kristen Kluska maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from $125 to $170.